ARS Pharmaceuticals, Inc. Common Stock (SPRY) is a publicly traded Healthcare sector company. As of October 28, 2026, SPRY trades at $3.61 with a market cap of $370.94M and a P/E ratio of -1.96. SPRY moved -2.14% today. Year to date, SPRY is -68.23%; over the trailing twelve months it is -61.13%. Its 52-week range spans $3.53 to $18.90. Analyst consensus is strong buy with an average price target of $22.50. Rallies surfaces SPRY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest SPRY news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $3.61 |
| Market Cap | $370.94M |
| P/E Ratio | -1.96 |
| EPS | $-2.18 |
| Dividend Yield | 0.00% |
| 52-Week High | $18.90 |
| 52-Week Low | $3.53 |
| Volume | 2.24M |
| Avg Volume | 0 |
| Revenue (TTM) | $116.93M |
| Net Income | $-215.43M |
| Gross Margin | 0.00% |
3 analysts cover SPRY: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $22.50.